Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other financing activities: 2017-2024

Historic Other financing activities for Solid Biosciences (SLDB) over the last 5 years, with Dec 2024 value amounting to $5.1 million.

  • Solid Biosciences' Other financing activities was N/A to $286,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2024, which is N/A change from last year.
  • Per Solid Biosciences' latest filing, its Other financing activities stood at $5.1 million for FY2024, which was up 34.85% from $3.8 million recorded in FY2020.
  • Solid Biosciences' Other financing activities' 5-year high stood at $5.1 million during FY2024, with a 5-year trough of $3.8 million in FY2020.
  • In the last 1 years, Solid Biosciences' Other financing activities had a median value of $5.1 million in 2024 and averaged $5.1 million.
  • Data for Solid Biosciences' Other financing activities shows a peak YoY spiked of 80.30% (in 2020) over the last 5 years.
  • Solid Biosciences' Other financing activities (Yearly) stood at $3.8 million in 2020, then followed by $5.1 million in 2024.